Bukwang Pharmaceutical Co., Ltd. (KOSE:A003000) announces a share repurchase program. Under the program, the company will repurchase up to 1,916,000 shares. The purpose of the program is to incinerate plan post acquisition of treasury stock. The program will expire on April 7, 2020. As of January 7, 2020, the company had 2,575,314 shares in treasury within scope available for dividend and had 5,083 shares in treasury through other repurchase.